The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 53.00
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.66%)
Open: 54.50
High: 54.50
Low: 54.50
Prev. Close: 54.50
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Award & PFAS Update

3 Jul 2023 14:37

RNS Number : 7955E
MyCelx Technologies Corporation
03 July 2023
 

3 July 2023

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Contract Award & PFAS Update

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce a contract award with a new client in the Middle East.

 

The client required an efficient, reliable system that could treat complex wastewater. MYCELX was selected specifically for its capability to treat the toughest water challenges successfully and cost-effectively and for its longstanding reputation in the region. The Company expects ca.$1 million in revenue in 2023 which underpins the current forecast for 2023. 

 

The Company continues to move forward with its PFAS pilot trials in several different applications. In July, a landfill leachate trial will commence and operate for up to two months utilizing MYCELX's proprietary P-Fluormer™ media technology. A drinking water trial will begin later in July testing P-Fluormer™ media to demonstrate compliance with the latest proposed EPA National Primary Drinking Water Regulation standards ("NPDWR") for PFOA and PFOS, along with four additional PFAS components. The next trial will be a landfill leachate application and will operate for up to six weeks, and will utilize multiple proprietary technologies from MYCELX, including REGEN, PFAS cartridges and P-Fluormer™ media. These trials will result in important data for numerous PFAS applications, which will accelerate adoption of our unique and cost-effective solution. We continue to focus on teaming and trialling with strategic partners in our key markets as well as effective marketing through webinars, conferences, social media and an upgraded website, which will be rolled out in the coming months. 

 

Connie Mixon, CEO, commented:

 

"We are thrilled to be expanding our customer base and application offering in Saudi Arabia. Our patented technology together with our extensive local experience have ensured MYCELX is recognised by waste management companies as a leading technology solution provider for industrial water treatment. 

 

In the burgeoning PFAS market, we continue to get traction with targeted strategic partners and direct customers as we pilot our technology in a series of trials. Specific data collection in different PFAS applications is key to accelerating our solution in this large and lucrative market."

 

 

For further information, please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Gordon Hamilton

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

 

Tel: +44 20 7770 6424

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBXGDRSXGDGXX
Date   Source Headline
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.